The medication operates by diminishing your appetite, leading to a reduction in calorie intake and gradual weight loss. Semaglutide, its active ingredient, falls under the category of GLP-1 agonists, akin to the weight loss drug Saxenda. These medications function by stimulating the production of GLP-1 hormone, influencing hunger levels. Elevated GLP-1 levels decelerate digestion and stomach emptying, prolonging the feeling of fullness and consequentially reducing food consumption. This sustained effect over time contributes to weight loss.

Wegovy has the potential to induce severe side effects, which may include the formation of thyroid tumours, including cancer. If you experience symptoms such as neck lumps or swelling, hoarseness, difficulty swallowing, or shortness of breath, promptly inform your healthcare provider. Animal studies have shown that Wegovy and drugs like it have led to thyroid tumour development, including thyroid cancer. However, it remains uncertain whether Wegovy can trigger thyroid tumours, or a specific type of thyroid cancer known as medullary thyroid carcinoma (MTC) in humans. Avoid using Wegovy if you or any of your relatives have a history of medullary thyroid carcinoma (MTC) or if you suffer from a condition of the endocrine system known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). For the full list of Side Effect please refer to the Patient Information Leaflet or consult your doctor.

If you are someone who is unable to take Wegovy take a look at our Weight Loss Products homepage where we have plenty of alternatives such as Alli Tablets

 This medication will only be prescribed to individuals with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher coupled with a weight-related condition such as type 2 diabetes, high cholesterol, or high blood pressure. Individuals who are pregnant or breastfeeding, have previously experienced a reaction to Semaglutide, or have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple endocrine neoplasia type 2 (MEN 2). Various risks may render the medication unsuitable for certain individuals, including those with gallbladder issues, a history of pancreatitis, mental health disorders, thyroid problems, diabetic complications, heart rate abnormalities, kidney issues, or digestive disorders such as Crohn’s disease should not buy semaglutide. It is imperative to always consult your doctor before initiating any medication regimen. For Further details on who should not use this medication please consult the Patient Information Leaflet.

Wegovy comes in a pre-filled injection pen for self-administration once weekly. You must Carefully prepare the needle each time, so you know that the pen is safe and ready to use. Details on how to correctly do this are stated in the Patient Information Leaflet or go to the Wegovy website for more information and illustrations.

As Wegovy is a prescription-based medicine, it may not be suitable for all individuals. Why not look at our Weight Loss Products Home page where we have a variety of options tailored to each individual, where you can buy Wegovy UK online and see plenty of alternatives.